235 related articles for article (PubMed ID: 35896836)
1. Multi-lesion radiomics of PET/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma.
Zhao M; Kluge K; Papp L; Grahovac M; Yang S; Jiang C; Krajnc D; Spielvogel CP; Ecsedi B; Haug A; Wang S; Hacker M; Zhang W; Li X
Eur Radiol; 2022 Oct; 32(10):7056-7067. PubMed ID: 35896836
[TBL] [Abstract][Full Text] [Related]
2. Machine learning based on clinico-biological features integrated
Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
[TBL] [Abstract][Full Text] [Related]
3. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
Huang B; Sollee J; Luo YH; Reddy A; Zhong Z; Wu J; Mammarappallil J; Healey T; Cheng G; Azzoli C; Korogodsky D; Zhang P; Feng X; Li J; Yang L; Jiao Z; Bai HX
EBioMedicine; 2022 Aug; 82():104127. PubMed ID: 35810561
[TBL] [Abstract][Full Text] [Related]
4. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
5. Combination of
Li S; Li Y; Zhao M; Wang P; Xin J
Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542
[TBL] [Abstract][Full Text] [Related]
6. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
Grahovac M; Spielvogel CP; Krajnc D; Ecsedi B; Traub-Weidinger T; Rasul S; Kluge K; Zhao M; Li X; Hacker M; Haug A; Papp L
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1607-1620. PubMed ID: 36738311
[TBL] [Abstract][Full Text] [Related]
7. Predicting pathological highly invasive lung cancer from preoperative [
Onozato Y; Iwata T; Uematsu Y; Shimizu D; Yamamoto T; Matsui Y; Ogawa K; Kuyama J; Sakairi Y; Kawakami E; Iizasa T; Yoshino I
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):715-726. PubMed ID: 36385219
[TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
9. Applications of radiomics-based analysis pipeline for predicting epidermal growth factor receptor mutation status.
Liu Z; Zhang T; Lin L; Long F; Guo H; Han L
Biomed Eng Online; 2023 Feb; 22(1):17. PubMed ID: 36810090
[TBL] [Abstract][Full Text] [Related]
10. Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.
Kawakita N; Toba H; Kawakami Y; Takizawa H; Bando Y; Otuska H; Matsumoto D; Takashima M; Tsuboi M; Yoshida M; Kondo K; Tangoku A
Int J Clin Oncol; 2020 Jun; 25(6):1079-1089. PubMed ID: 32130543
[TBL] [Abstract][Full Text] [Related]
11. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
[TBL] [Abstract][Full Text] [Related]
12. PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter study.
Zhong Y; Cai C; Chen T; Gui H; Chen C; Deng J; Yang M; Yu B; Song Y; Wang T; Chen Y; Shi H; Xie D; Chen C; She Y
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):521-534. PubMed ID: 37725128
[TBL] [Abstract][Full Text] [Related]
13. [The correlation between metabolic parameters in (18)F-FDG PET-CT and solid and micropapillary histological subtypes in lung adenocarcinoma].
Guo Y; Yao ZM; Chen M; Chen CX
Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):555-561. PubMed ID: 35754230
[No Abstract] [Full Text] [Related]
14. CT-based radiomics and machine learning to predict spread through air space in lung adenocarcinoma.
Jiang C; Luo Y; Yuan J; You S; Chen Z; Wu M; Wang G; Gong J
Eur Radiol; 2020 Jul; 30(7):4050-4057. PubMed ID: 32112116
[TBL] [Abstract][Full Text] [Related]
15.
Liu F; Xiang Z; Li Q; Fang X; Zhou J; Yang X; Lin H; Yang Q
Clin Radiol; 2024 Jan; 79(1):e147-e155. PubMed ID: 37884401
[TBL] [Abstract][Full Text] [Related]
16. Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics.
Zhang Y; Liu H; Chang C; Yin Y; Wang R
PLoS One; 2024; 19(4):e0300170. PubMed ID: 38568892
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma.
Jiang M; Guo X; Chen P; Zhang X; Gao Q; Zhang J; Zheng J
PeerJ; 2024; 12():e16807. PubMed ID: 38250731
[TBL] [Abstract][Full Text] [Related]
18. Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy CT images.
Bae JM; Jeong JY; Lee HY; Sohn I; Kim HS; Son JY; Kwon OJ; Choi JY; Lee KS; Shim YM
Oncotarget; 2017 Jan; 8(1):523-535. PubMed ID: 27880938
[TBL] [Abstract][Full Text] [Related]
19. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
[TBL] [Abstract][Full Text] [Related]
20. Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment [
Nakajo M; Jinguji M; Tani A; Kikuno H; Hirahara D; Togami S; Kobayashi H; Yoshiura T
Mol Imaging Biol; 2021 Oct; 23(5):756-765. PubMed ID: 33763816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]